CBS Evening News Online Edition - 2004-12-14
Channel: malgent
Transcript
Language: English (original, YouTube automatic captions)
[0:00] Hello, I'm Dan Rather and welcome to the
[0:02] CBS Evening News online edition. Just
[0:05] ahead, bioteterrorism readiness. A
[0:08] disturbing new report shows just how
[0:10] unready most American cities are. Also,
[0:13] how safe is one of the most powerful
[0:16] cholesteroling drugs. We'll give you a
[0:19] hard look in our ongoing CBS News
[0:21] investigation and call it the library
[0:24] that never closes. We'll show you plans
[0:27] for a worldwide virtual library. It's
[0:30] all starting now on the CBS Evening News
[0:33] online edition.
[0:35] >> It's been more than 3 years since the
[0:37] 9/11 attacks, more than 3 years since
[0:40] the still unsolved anthrax attacks. And
[0:43] there are serious questions tonight
[0:45] about just how prepared this country is
[0:47] for another attack, an attack of
[0:50] bioteterrorism. A new report says that
[0:52] while some progress has been made, a lot
[0:55] more needs to be done that hasn't been
[0:57] done. On a readiness scale of 1 to 10,
[1:00] only Florida and North Carolina scored
[1:03] as high as nine. Alaska and
[1:05] Massachusetts are least prepared,
[1:07] scoring a three. CBS's Jim Stewart
[1:10] reports tonight on the continuing
[1:12] bioteterror risk. There may not be a
[1:15] better place to start an epidemic. And
[1:18] to prove it, in the closed confines of a
[1:20] Chicago hockey arena last year,
[1:22] officials staged the mock release of
[1:24] plague germs just to see what would
[1:26] happen. Within a day, they had their
[1:28] answer. First in twos and threes.
[1:31] >> I've been nauseous. I've had muscle
[1:32] aches.
[1:33] >> Then by the dozens and finally by the
[1:35] bus loads. Eventually, pretend victims
[1:37] clogged the hallways. Chicago hospitals
[1:40] were overwhelmed. The final estimate on
[1:42] dead and dying in the tens of thousands.
[1:45] And a bipartisan health group's report
[1:47] on bioteterrorism today suggested
[1:49] Chicago wouldn't be the only city
[1:51] overwhelmed. Only six states are
[1:54] prepared to distribute vaccines. The
[1:56] report found nearly 60% of all states
[1:58] don't have enough lab scientists. And
[2:00] nowhere is that knowledge causing more
[2:02] uneasiness than here, where Washington
[2:04] is about to host a repeat of the Bush
[2:06] inauguration. Bio sensors like these are
[2:09] scattered about the city, snipping the
[2:11] air constantly for deadly agents.
[2:14] Details are secret, but the general plan
[2:16] is that if they were to hit on
[2:17] something, say during the inaugural
[2:19] parade, the president would head here to
[2:22] a nondescript back door at the
[2:23] Washington Hospital Center.
[2:25] >> And then he would go in here and let me
[2:27] turn on the shower. He'd strip down,
[2:29] walk through these showers, and enter
[2:31] this airlocked room, which looks sort of
[2:33] what it once was, a storage shed with a
[2:36] dirt floor. Only now, it's one of the
[2:39] most state-of-the-art chemical bio
[2:40] treatment rooms in America. There's just
[2:42] one problem. In the worst possible
[2:45] scenario, how many people could you jam
[2:46] in here?
[2:47] >> We could put a hundred. We could put 100
[2:48] patients in here.
[2:50] >> Just 100.
[2:50] >> Just 100. And again,
[2:51] >> what if you got 500 to show up at the
[2:53] front door?
[2:53] >> That's That's a good question.
[2:55] >> And this, remember, is considered one of
[2:56] the best in the land. and it cost $1.8
[2:59] million. What we really need, say
[3:01] experts, is this, the
[3:03] counterboteterrorism emergency room of
[3:05] the future, ER1 they call it, where
[3:08] thousands of patients could be sorted,
[3:10] treated, and isolated. The first will be
[3:13] built in Washington, just around the
[3:15] corner from that converted shed. The
[3:17] only thing is construction doesn't even
[3:19] start for another 18 months. Jim
[3:22] Stewart, CBS News, Washington. In health
[3:25] news tonight, CBS News has long been
[3:27] investigating the safety of statin drugs
[3:30] taken by millions of people trying to
[3:32] lower their cholesterol. A small number
[3:35] of them suffer what they say are serious
[3:37] side effects. But are some statin drugs
[3:40] more dangerous than others? CBS's Cheryl
[3:43] Atkinson has this follow-up report.
[3:46] >> Crestor is considered the most potent
[3:48] cholesterol lowering statin drug around.
[3:51] Since Katie switched to Crestor, her
[3:53] cholesterol is much less.
[3:54] >> But does it stand out in another way?
[3:57] Serious side effects. Richard Turnbo
[3:59] took Crestor for 2 months before his
[4:01] wife Karen had to rush into the
[4:03] hospital.
[4:04] >> They even had notified Karen that she
[4:07] needed to get my children to the
[4:08] hospital if they were going to possibly
[4:11] see me because they weren't expecting me
[4:13] to pull through this. Doctors consider
[4:16] Crestor a prime suspect in a muscle
[4:18] disorder which shut down his kidneys,
[4:20] rabdtomyalysis.
[4:22] It's a slight risk of all statins, but
[4:24] the consumer group Public Citizen has
[4:26] asked the FDA to ban Crestor, saying it
[4:29] causes so much rabdomiialysis, it's
[4:31] right up there with another statin
[4:33] already pulled from the market, Bakeol.
[4:36] and severe kidney problems while rare
[4:38] are reported with Crestor at a rate
[4:40] that's 75 times higher than the average
[4:43] of all other statins according to public
[4:45] citizen. Crestor's maker Astroenica
[4:48] insists the drug has been extensively
[4:50] studied and is as safe as any.
[4:52] >> When we look at the rates of
[4:54] rabdomiialysis, the rates of kidney
[4:56] failure with regard to Crestor, the
[4:58] rates are less than 1 in 10,000.
[5:01] They're similar rates to what we see
[5:02] with other statins that are out on the
[5:04] market. But Crestor is the only statin
[5:06] where kidney problems turned up in
[5:08] studies before its approval. The FDA
[5:10] resolved those concerns by allowing only
[5:13] lower doses of the drug to be sold.
[5:15] Still, serious adverse events have
[5:17] prompted a label change in Europe, two
[5:19] warnings in Canada, and a health
[5:21] advisory in the US. The FDA officially
[5:24] maintains CET is safe, but one FDA
[5:27] scientist has broken ranks. Crestor is
[5:30] the only statin among all the marketed
[5:33] statins that has acute renal failure.
[5:36] That is acute kidney failure.
[5:38] >> Why do you think it is that these people
[5:40] are singling out Crestor among the
[5:42] statins if Cster doesn't have unique
[5:45] concerns?
[5:46] >> I can't speak for what their motivations
[5:48] are. Cheryl, we feel that Crestor has
[5:50] been treated unfairly. That's true. We
[5:53] think it's a great drug. You know, we
[5:55] have a lot of confidence in this drug.
[5:57] Confidence backed by an estimated
[5:59] billion dollar promotional campaign. Now
[6:02] at least two PR firms are helping
[6:04] Astroynica counter bad publicity.
[6:07] Turnbo's kidneys healed after he quit
[6:09] taking Crestor, but lingering muscle
[6:11] problems have put him back in the
[6:12] hospital twice.
[6:14] >> I know my doctor today, he wouldn't put
[6:16] me back on it.
[6:18] >> Even so, his doctor hasn't stopped
[6:20] prescribing Crestor entirely. Like many
[6:22] others, he thinks the jury is still out
[6:25] and is waiting for a definitive word on
[6:27] whether Questtor is riskier.
[6:29] >> Cheryl Atinson, CBS News, Washington.
[6:32] >> There could soon be a lot more
[6:34] information available to you on the
[6:35] internet. Millions of pages of data now
[6:38] unavailable would be just a point
[6:40] andclick away through the search engine
[6:42] Google. CBS's Jim Atarrod reports some
[6:45] big libraries think the idea is long
[6:47] overdue.
[6:49] Not to say major changes in libraries
[6:51] are rare, but the last one this big was
[6:54] half a millennium ago. The printing
[6:56] press. Well, Gutenberg, meet Google.
[7:00] >> Users worldwide will be able to access
[7:03] information that was previously
[7:05] inaccessible to them.
[7:06] >> Google, the internet's number one search
[7:09] engine, isn't just for finding hot shots
[7:11] of Charize Theron anymore.
[7:13] >> It's putting the vast repositories of
[7:15] the world's great libraries a mouse
[7:17] click away.
[7:18] Google is making deals with some of the
[7:20] world's most prestigious universities to
[7:22] digitize their non-copyrighted
[7:25] collections and put them online. The
[7:28] Google project is the next big step in
[7:30] how human beings keep track of and
[7:32] distribute everything we know. For
[7:34] centuries, you had to go to the books.
[7:36] The books didn't come to you. And while
[7:38] the computer's gradually been changing
[7:40] that, the evolution's about to have a
[7:42] revolution. More than 15 million volumes
[7:45] will be scanned into the Google
[7:47] database. At a 100,000 pages a day, it
[7:49] could still take 10 years and $150
[7:52] million to complete.
[7:54] >> Big deal.
[7:56] >> Huge. Transformative.
[7:58] >> Paul the clerk who runs the New York
[7:59] Public Library loves the idea. To him,
[8:02] the library business is all about
[8:04] access. Aren't you worried that 50 years
[8:07] from now there is New York no New York
[8:09] City public library?
[8:10] >> No. I think that one has to see this in
[8:12] the same way that one saw television not
[8:16] replacing radio but supplementing it.
[8:20] >> He's got a point.
[8:21] >> After all, libraries aren't due for a
[8:23] change this big for another 500 years.
[8:27] Jim Axor, CBS News, New York. More
[8:30] stories are just a click away, but be
[8:32] sure to join me on television for the on
[8:34] air edition of the CBS Evening News. On
[8:37] Wednesday's broadcast, turning garbage
[8:39] into gold, the end product of a million
[8:42] workers nets a young entrepreneur a
[8:45] fortune. What are they making? We'll
[8:47] show you when the worm turns. For
[8:51] cbsnews.com,
[8:52] I'm Dan Rather.